Allergic Rhinitis With/Without Asthma: Pre- and Post-Qipian Analysis

Completed

• Conditions: Rhinitis, Allergic; Asthma

• Registration Number: NCT06573164
• Lead Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2024-8-13
• Last Update Posted: 2 September 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Inclusion Criteria:<br><br> - Patients with rhinitis who meet the ARIA (Allergic Rhinitis and Its Impact on<br> Asthma) guidelines.<br><br> - Patients with asthma who meet the GINA (Global Initiative for Asthma) guidelines.<br><br>Exclusion Criteria:<br><br> - Patients undergoing combined dust mite-specific immunotherapy<br><br> - Patients undergoing combined treatment with biologics, including omalizumab,<br> dupilumab, or mepolizumab.<br><br> - Patients undergoing combined treatment with small molecule drugs, including<br> upadacitinib, abrocitinib, baricitinib, and other JAK inhibitors.<br><br> - Patients who are unwilling to comply with treatment, are unable to adhere to regular<br> medication schedules, and do not attend follow-up appointments.

Exclusion Criteria

Not provided

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Asthma Control Test(ACT);Concentration of immunoglobulin E (IgE);Concentration of immunoglobulin A (IgA);Concentration of immunoglobulin G (IgG);Concentration of Interleukin-4 (IL-4);Concentration of Interleukin-13 (IL-13);Concentration of Interleukin-10 (IL-10);Total Nasal Symptom Score (TNSS)